Accretion Therapeutics, Inc.
CIK 2109293 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Accretion Therapeutics, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Feb 17, 2026 | D | 0002109293-26-000001 |